promising targets beyond flt3 in aml: idh1/2 & menin
Published 1 year ago • 115 plays • Length 1:56Download video MP4
Download video MP3
Similar videos
-
2:29
combining menin/flt3/bcl2 inhibition as a treatment approach in flt3/npm1 double mutated aml
-
0:49
treatment avenues for patients with r/r flt3-mutated aml: optimizing flt3 inhibitors
-
1:40
sf3b1 as therapeutic target in flt3/itd positive aml
-
1:12
the value of flt3 inhibitors in aml and focus for future trial designs
-
1:44
new targets to treat acute myeloid leukemia (aml) with flt3 mutations
-
10:23
my acute myeloid leukemia (aml) relapse story
-
11:06
how could new treatment options improve outcomes in flt3-mutated aml?
-
2:47
all about gilteritinib: when is gilteritinib used to treat flt3-positive aml? #aml
-
1:06
investigating the molecular and clinical features of flt3-jmd mutations in aml
-
1:52
the management of r/r flt3-mutated aml
-
3:14
flt3 mutations for targeted therapy in aml
-
1:32
novel treatment combinations for flt3-mutated aml
-
2:15
targeting flt3 in aml
-
1:23
the promise of combining venetoclax with gilteritinib for the treatment of flt3-mutated aml
-
4:09
quantum-r: quizartinib looks promising for flt3-itd mutated aml
-
1:30
triplet combinations in flt3-mutated aml
-
1:40
second-generation flt3 inhibitors in the treatment of flt3-itd aml
-
1:59
tangible benefit for flt3-itd r/r aml on quizartinib
-
1:34
advances and unmet needs in second-line treatment of dlbcl
-
1:33
clinical trials investigating treatment approaches for flt3-mutated and idh-mutated aml patients
-
1:30
a phase i trial investigating a novel oral flt3 inhibitor, bmf-500, in flt3-mutant aml
-
1:24
mechanisms of resistance to flt3 inhibitors in aml and strategies to overcome this